Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study”
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-08-01
|
Series: | Journal of the Formosan Medical Association |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0929664625000336 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839613689991266304 |
---|---|
author | Yan Wang Yansong Li |
author_facet | Yan Wang Yansong Li |
author_sort | Yan Wang |
collection | DOAJ |
format | Article |
id | doaj-art-db9e4c516cc8426c8f6f12d68039fd40 |
institution | Matheson Library |
issn | 0929-6646 |
language | English |
publishDate | 2025-08-01 |
publisher | Elsevier |
record_format | Article |
series | Journal of the Formosan Medical Association |
spelling | doaj-art-db9e4c516cc8426c8f6f12d68039fd402025-07-27T04:55:16ZengElsevierJournal of the Formosan Medical Association0929-66462025-08-011248775Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study”Yan Wang0Yansong Li1Anesthesiology department, Shiyan Maternal and Child Health Hospital, Hubei, ChinaNursing department, Shiyan Maternal and Child Health Hospital, Hubei, China; Corresponding author.http://www.sciencedirect.com/science/article/pii/S0929664625000336 |
spellingShingle | Yan Wang Yansong Li Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study” Journal of the Formosan Medical Association |
title | Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study” |
title_full | Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study” |
title_fullStr | Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study” |
title_full_unstemmed | Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study” |
title_short | Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study” |
title_sort | comment on efficacy and safety of oxaliplatin based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer a single center retrospective cohort study |
url | http://www.sciencedirect.com/science/article/pii/S0929664625000336 |
work_keys_str_mv | AT yanwang commentonefficacyandsafetyofoxaliplatinbasedhyperthermicintraperitonealchemotherapywithsecondarycytoreductionforplatinumresistantrecurrentovariancancerasinglecenterretrospectivecohortstudy AT yansongli commentonefficacyandsafetyofoxaliplatinbasedhyperthermicintraperitonealchemotherapywithsecondarycytoreductionforplatinumresistantrecurrentovariancancerasinglecenterretrospectivecohortstudy |